Literature DB >> 16638992

Promotion of corneal epithelial wound healing in vitro and in vivo by annexin A5.

Masanao Watanabe1, Shoichi Kondo, Ken Mizuno, Wataru Yano, Hiroshi Nakao, Yukio Hattori, Kazuhiro Kimura, Teruo Nishida.   

Abstract

PURPOSE: To investigate the effect of annexin A5, a calcium-dependent phospholipid-binding protein, on corneal epithelial wound healing.
METHODS: The effect of annexin A5 on migration of rabbit corneal epithelial (RCE) cells in vitro was examined in scrape-wounded cell monolayers. The effect of annexin A5 on the release of urokinase-type plasminogen activator (uPA) from cultured RCE cells was determined by zymography, fluorogenic assay of PA activity, and enzyme-linked immunosorbent assay. The proliferation of RCE cells was assessed by measurement of [3H]thymidine incorporation. The effect of annexin A5 on corneal wound closure in rabbits was investigated after removal of the corneal epithelium, either by exposure to iodine vapor or surgically. Eye drops containing annexin A5 were instilled into one eye and vehicle into the other. The area of the epithelial defect was measured at various times after wounding, and the healing rate was calculated by linear regression analysis.
RESULTS: Annexin A5 significantly promoted the migration of RCE cells in a wounded monolayer. However, annexin A5 had no effect on RCE cell proliferation. Annexin A5 also increased the release of uPA both from wounded RCE cell monolayers and from nonwounded semiconfluent RCE cells. In both models of corneal wound closure, the healing rate was significantly increased by instillation of eye drops containing annexin A5 compared with that apparent in the eyes that received vehicle.
CONCLUSIONS: Annexin A5 promoted corneal epithelial wound healing both in vitro and in vivo. Upregulation of uPA release from corneal epithelial cells may contribute to this effect of annexin A5.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16638992     DOI: 10.1167/iovs.05-0591

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  7 in total

1.  Dry eye and designer ophthalmics.

Authors:  Gordon W Laurie; Leslie A Olsakovsky; Brian P Conway; Robert L McKown; Kazuko Kitagawa; Jason J Nichols
Journal:  Optom Vis Sci       Date:  2008-08       Impact factor: 1.973

2.  [Simulation of corneal epithelial injuries by mechanical and corrosive damage : Influence of fetal bovine serum and dexpanthenol on epithelial regeneration in a cell culture model].

Authors:  M Hahne; S Reichl
Journal:  Ophthalmologe       Date:  2010-06       Impact factor: 1.059

3.  Domain IV of Annexin A5 Is Critical for Binding Calcium and Guarantees Its Maximum Binding to the Phosphatidylserine Membrane.

Authors:  Jie Wang; Jing Liu; Yulu Cao; Minjin Hu; Zichun Hua
Journal:  Molecules       Date:  2017-12-19       Impact factor: 4.411

4.  A Novel Therapeutic Approach to Corneal Alkaline Burn Model by Targeting Fidgetin-Like 2, a Microtubule Regulator.

Authors:  Jessie Wang; Abhinav Dey; Adam H Kramer; Yuan Miao; Juan Liu; Lisa Baker; Joel M Friedman; Parimala Nacharaju; Roy S Chuck; Cheng Zhang; David J Sharp
Journal:  Transl Vis Sci Technol       Date:  2021-01-08       Impact factor: 3.283

5.  Silk films with nanotopography and extracellular proteins enhance corneal epithelial wound healing.

Authors:  Yuncin Luo; Kai B Kang; Rachel Sartaj; Michael G Sun; Qiang Zhou; Victor H Guaiquil; Mark I Rosenblatt
Journal:  Sci Rep       Date:  2021-04-14       Impact factor: 4.996

6.  Molecular signatures that correlate with induction of lens regeneration in newts: lessons from proteomic analysis.

Authors:  Konstantinos Sousounis; Rital Bhavsar; Mario Looso; Marcus Krüger; Jessica Beebe; Thomas Braun; Panagiotis A Tsonis
Journal:  Hum Genomics       Date:  2014-12-11       Impact factor: 4.639

7.  Annexin A5 regulates Leydig cell testosterone production via ERK1/2 pathway.

Authors:  Ze He; Qin Sun; Yuan-Jiao Liang; Li Chen; Yi-Feng Ge; Shi-Feng Yun; Bing Yao
Journal:  Asian J Androl       Date:  2016 May-Jun       Impact factor: 3.285

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.